Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience.
نویسندگان
چکیده
The technical challenges in the development of a quality-controlled registry of percutaneous coronary interventions (PCIs) are currently unknown. This article describes the authors' experience in the development of a regional, quality-controlled PCI registry. In 1996, 16 centers in Michigan were invited to participate in a multicenter PCI registry. Nine centers agreed to a pilot data collection and, as of July 2001, eight centers are still actively collecting data. An Oracle database was developed by the coordinating center. A common data collection form and a standard set of definitions were agreed on during several meetings. Data validity was insured through review of each form by a trained nurse, by automatic database diagnostic routines, and by site visits that included a review of the catheterization laboratory logs and a review of randomly selected charts. The average number of forms requiring query resolution was 33% in 1997 (range 7-76%), and it decreased to 5% in 1999 (range 1.4-10%). The most commonly queried variables were outcomes prior to discharge, lesion category, lesion complexity, date of birth, device used, gender, postprocedural percent stenosis, presence of left main disease, and MI date. Invalid dates, identification of the doctor, the presence of duplicate forms, and of duplicate outcomes were additional common queries generated by the internal diagnostic routines. In conclusion, the number of queries and diagnostic reports generated in the database suggests that the development of a quality-controlled PCI registry requires the institution of a careful diagnostic and data quality assessment system.
منابع مشابه
The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions.
The past decade has been characterized by increased scrutiny of outcomes of surgical and percutaneous coronary interventions (PCIs). This increased scrutiny has led to the development of regional, state, and national databases for outcome assessment and for public reporting. This report describes the initial development of a regional, collaborative, cardiovascular consortium and the progress ma...
متن کاملPartnering to Improve Outcomes
http://ccn.aacnjournals.org Sandra Lins is the Blue Cross/Blue Shield Michigan Cardiovascular Consortium project coordinator at Oakwood Hospital and Medical Center in Dearborn, Mich. She coordinates all data collection and quality improvement efforts related to percutaneous coronary interventions. Denise Guffey is the former manager of the cardiac catheterization laboratory at Oakwood Hospital ...
متن کاملThe safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
n this issue of the Journal, Gurm et al. (1) present bservational data showing no apparent difference in early utcome among primary percutaneous coronary intervenion (PCI) patients receiving the small-molecule platelet lycoprotein (GP) IIb/IIIa inhibitor eptifibatide versus hose receiving the monoclonal antibody abciximab. Their ndings are from the Blue Cross Blue Shield of Michigan ardiovascul...
متن کاملThe Epidemiology and Outcomes of Percutaneous Coronary Intervention Before High‐Risk Noncardiac Surgery in Contemporary Practice: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry
BACKGROUND Percutaneous coronary intervention (PCI) is sometimes performed with the intent to lower cardiovascular risk before high-risk noncardiac surgery (HRNCS). There are limited data on the frequency and outcome of PCIs performed in this setting. METHODS AND RESULTS We assessed the frequency, characteristics, and in-hospital outcomes of patients undergoing PCI as part of the preoperative...
متن کاملThe quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions.
BACKGROUND Peripheral arterial disease is a manifestation of systemic atherosclerosis and is predictive of future cardiovascular events. Clinical trial data have demonstrated that medical therapy can attenuate cardiovascular morbidity and mortality in patients with peripheral arterial disease. The utilization and impact of recommended medical therapy in a contemporary population of patients who...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of interventional cardiology
دوره 15 5 شماره
صفحات -
تاریخ انتشار 2002